Hytonen, Jarkko ORCID: 0000-0001-9120-7645, Leppanen, Olli, Braesen, Jan Hinrich, Schunck, Wolf-Hagen, Mueller, Dominik, Jung, Friedrich, Mrowietz, Christoph, Jastroch, Martin, von Bergwelt-Baildon, Michael, Kappert, Kai ORCID: 0000-0001-6976-0428, Heuser, Arnd ORCID: 0000-0002-3334-960X, Drenckhahn, Joerg-Detlef, Pieske, Burkert, Thierfelder, Ludwig, Yla-Herttuala, Seppo ORCID: 0000-0001-7593-2708 and Blaschke, Florian (2016). Activation of Peroxisome Proliferator-Activated Receptor- as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis. Arterioscler. Thromb. Vasc. Biol., 36 (8). S. 1534 - 1549. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1524-4636

Full text not available from this repository.

Abstract

Objective Drug-eluting coronary stents reduce restenosis rate and late lumen loss compared with bare-metal stents; however, drug-eluting coronary stents may delay vascular healing and increase late stent thrombosis. The peroxisome proliferator-activated receptor-delta (PPAR) exhibits actions that could favorably influence outcomes after drug-eluting coronary stents placement. Approach and Results Here, we report that PPAR ligand-coated stents strongly reduce the development of neointima and luminal narrowing in a rabbit model of experimental atherosclerosis. Inhibition of inflammatory gene expression and vascular smooth muscle cell (VSMC) proliferation and migration, prevention of thrombocyte activation and aggregation, and proproliferative effects on endothelial cells were identified as key mechanisms for the prevention of restenosis. Using normal and PPAR-depleted VSMCs, we show that the observed effects of PPAR ligand GW0742 on VSMCs and thrombocytes are PPAR receptor dependent. PPAR ligand treatment induces expression of pyruvate dehydrogenase kinase isozyme 4 and downregulates the glucose transporter 1 in VSMCs, thus impairing the ability of VSMCs to provide the increased energy demands required for growth factor-stimulated proliferation and migration. Conclusions In contrast to commonly used drugs for stent coating, PPAR ligands not only inhibit inflammatory response and proliferation of VSMCs but also prevent thrombocyte activation and support vessel re-endothelialization. Thus, pharmacological PPAR activation could be a promising novel strategy to improve drug-eluting coronary stents outcomes.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Hytonen, JarkkoUNSPECIFIEDorcid.org/0000-0001-9120-7645UNSPECIFIED
Leppanen, OlliUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Braesen, Jan HinrichUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schunck, Wolf-HagenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mueller, DominikUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jung, FriedrichUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mrowietz, ChristophUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jastroch, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von Bergwelt-Baildon, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kappert, KaiUNSPECIFIEDorcid.org/0000-0001-6976-0428UNSPECIFIED
Heuser, ArndUNSPECIFIEDorcid.org/0000-0002-3334-960XUNSPECIFIED
Drenckhahn, Joerg-DetlefUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pieske, BurkertUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Thierfelder, LudwigUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Yla-Herttuala, SeppoUNSPECIFIEDorcid.org/0000-0001-7593-2708UNSPECIFIED
Blaschke, FlorianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-268659
DOI: 10.1161/ATVBAHA.115.306962
Journal or Publication Title: Arterioscler. Thromb. Vasc. Biol.
Volume: 36
Number: 8
Page Range: S. 1534 - 1549
Date: 2016
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Place of Publication: PHILADELPHIA
ISSN: 1524-4636
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
VASCULAR SMOOTH-MUSCLE; DRUG-ELUTING STENTS; CELL-PROLIFERATION; PPAR-DELTA; HEART-DISEASE; AMP KINASE; GROWTH; PLATELETS; GAMMA; BETA/DELTAMultiple languages
Hematology; Peripheral Vascular DiseaseMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/26865

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item